Papers
3
Total Citations
324
H-Index
3
About
Paul Shinn is a prominent researcher specializing in high-throughput screening, in vitro toxicology, and computational approaches to chemical safety assessment. His work sits at the critical intersection of automation, robotics, and toxicological science, with a particular focus on developing scalable systems to evaluate the safety of environmental chemicals and drug candidates more efficiently than traditional animal-based methods. Shinn's most celebrated contribution is his foundational role in the Tox21 program, a landmark collaborative initiative that leveraged robotic platforms to assess environmental chemicals at unprecedented scale — work that has garnered over 255 citations and reshaped how the scientific community approaches chemical risk evaluation. His subsequent research on high-throughput screening has pushed boundaries further, addressing the pressing need for faster, more human-relevant alternatives to animal testing amid a growing chemical landscape and persistent drug development failures due to toxicity concerns. Beyond single-compound analysis, Shinn has also advanced the field of drug combination screening, exploring synergistic interactions with implications for both therapeutic development and safety science. Collectively, his work has helped modernize toxicology for the 21st century, making him an influential voice in translational research and regulatory science.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3High-Throughput Screening for Drug Combinations20 citations · 2019